The narrative of British deindustrialisation — factories closing, skills disappearing, whole communities hollowed out — is powerful and substantially true. But it is not the complete picture. In several sectors, British manufacturing is experiencing genuine growth driven by defence contracts, pharmaceutical production, aerospace components, and the emerging green industrial base.
Defence: The Biggest Driver
BAE Systems' order book, as noted elsewhere, has never been larger. This is not abstract good news for shareholders — it translates into employment and skills at facilities in Lancashire, Glasgow, Portsmouth, and Barrow-in-Furness. The supply chain that feeds these facilities — precision engineering, electronics, specialised materials — is also growing.
Pharmaceuticals
Britain's pharmaceutical manufacturing sector — historically dominated by GSK and AstraZeneca — has benefited from post-pandemic investment in domestic production capacity. The government's Life Sciences Manufacturing Strategy, while modest in scope, has supported several facility expansions.
Aerospace
Rolls-Royce, GKN Aerospace, and their supply chains represent a cluster of advanced manufacturing capability that is genuinely world-class. The civil aviation recovery has restored demand; the defence expansion has added to it.
The Skills Constraint
Every conversation with manufacturing leaders returns to the same bottleneck: the workforce. Technical skills — engineering, manufacturing processes, quality systems — take years to develop. Training capacity has not kept pace with growing demand.
